To the editor: C-kit mutations in core binding factor leukemias Positivity for CD117(c-kit) expression is present in 80% of acute myeloblastic leukemia (AML) cases,[1][1] and has been associated with the expression of CD33, a marker of myeloid precursors, and CD13, a myeloid-associated antigen.[2
No takes yet. Share an insight, caveat, or question.
Beghini et al. (2000) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: